Clinical trials

  • SIMVASTATIN for Alcoholic liver disease | Chronic liver disease | Liver fibrosis
  • LEBRIKIZUMAB for Atopic dermatitis
  • CART84 for Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) | Relapsed/refractory acute myeloid leukemia (AML)
  • Allogeneic adipose-derived adult mesenchymal stem cells expanded for Dry eye disease | Graft-versus-host disease
  • CTPS1 inhibitor (STP938) for Essential thrombocythaemia | Thrombocythaemia
  • FOSAPREPITANT for Post-operative nausea and vomiting (PONV)
  • Fludeoxyglucose (18F) for Alzheimer's disease
  • BMS-986517 for Advanced solid tumors
  • BOTULINUM TOXIN TYPE A for Hidradenitis Suppurativa
  • RINATABART SESUTECAN for Non-small cell lung cancer | Locally advanced or metastatic non-small cell lung cancer
  • AUTOLOGOUS ENRICHED T CELLS RETROVIRALLY TRANSDUCED TO EXPRESS TWO CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND CD22 for Systemic lupus erythematosus with active lupus nephritis
  • ADX-324 for Hereditary angioedema